US Stock MarketDetailed Quotes

DRIO DarioHealth

Watchlist
  • 0.6916
  • -0.0086-1.23%
Close May 7 16:00 ET
28.75MMarket Cap-1.13P/E (TTM)

DarioHealth Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
32.86%27.04M
110.29%7.6M
111.00%7.42M
1.67%6.26M
-18.50%5.76M
-26.41%20.35M
-46.89%3.62M
-46.74%3.52M
-0.50%6.15M
-12.33%7.07M
Operating revenue
32.86%27.04M
110.29%7.6M
111.00%7.42M
1.67%6.26M
-18.50%5.76M
-26.41%20.35M
-46.89%3.62M
-46.74%3.52M
-0.50%6.15M
-12.33%7.07M
Cost of revenue
-4.14%13.77M
-2.35%3.4M
21.94%3.55M
-14.20%3.5M
-14.67%3.33M
-20.18%14.37M
-14.55%3.48M
-39.48%2.91M
-19.17%4.08M
-4.30%3.9M
Gross profit
121.71%13.27M
3,083.33%4.2M
535.57%3.88M
32.88%2.76M
-23.23%2.43M
-38.02%5.98M
-95.17%132K
-66.11%610K
82.25%2.07M
-20.52%3.17M
Operating expense
14.22%71.01M
10.62%15.87M
-1.54%15.91M
17.73%18.95M
30.25%20.29M
-6.46%62.17M
22.19%14.35M
-1.33%16.16M
-12.97%16.09M
-21.56%15.58M
Selling and administrative expenses
11.70%46.83M
4.31%10.59M
-0.29%10.46M
11.64%12.14M
31.06%13.65M
-10.45%41.93M
45.85%10.15M
-9.33%10.49M
-24.27%10.87M
-25.26%10.41M
-Selling and marketing expense
10.78%26.35M
20.62%5.58M
5.81%6.73M
10.40%7.13M
8.99%6.91M
-21.56%23.79M
17.91%4.62M
-15.96%6.36M
-30.52%6.46M
-33.51%6.34M
-General and administrative expense
12.91%20.48M
-9.31%5.01M
-9.69%3.73M
13.44%5.01M
65.44%6.74M
9.99%18.14M
81.88%5.53M
3.23%4.13M
-12.79%4.41M
-7.37%4.07M
Research and development costs
19.41%24.18M
25.86%5.28M
-3.87%5.45M
30.41%6.81M
28.60%6.64M
3.05%20.25M
-12.25%4.2M
17.95%5.67M
26.23%5.22M
-12.86%5.17M
Operating profit
-2.77%-57.74M
17.92%-11.67M
22.62%-12.03M
-15.49%-16.19M
-43.90%-17.86M
1.09%-56.19M
-57.77%-14.22M
-6.68%-15.55M
19.22%-14.02M
21.82%-12.41M
Net non-operating interest income expense
-16.60%1.02M
-28.38%3.42M
-68.28%-313K
200.62%2.58M
7.83%-530K
156.18%1.22M
394.39%4.78M
82.44%-186K
-281.70%-2.57M
-2,513.64%-575K
Non-operating interest income
-40.26%1.12M
-65.74%161K
----
----
16.42%390K
269.17%1.87M
69.06%470K
----
----
8,275.00%335K
Total other finance cost
-85.12%96K
24.30%-3.26M
68.28%313K
-200.62%-2.58M
1.10%920K
-20.07%645K
-18,037.50%-4.31M
-82.44%186K
281.70%2.57M
3,400.00%910K
Other net income (expense)
375.76%12.13M
74.29%-1.23M
5,732.91%9.22M
-37.32%-4.4M
-141.22%-4.78M
818.18%158K
Gain on sale of security
375.76%12.13M
74.29%-1.23M
----
----
5,732.91%9.22M
-37.32%-4.4M
-141.22%-4.78M
----
----
818.18%158K
Income before tax
24.87%-44.6M
33.36%-9.48M
21.54%-12.34M
17.94%-13.61M
28.51%-9.17M
4.54%-59.36M
-12.75%-14.22M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
Income tax
-2,993.75%-1.85M
142.19%155K
-13K
0
-1.99M
1,500.00%64K
2,033.33%64K
0
0
0
Net income
28.07%-42.75M
32.57%-9.63M
21.62%-12.33M
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
Net income continuous Operations
28.07%-42.75M
32.57%-9.63M
21.62%-12.33M
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
Minority interest income
Net income attributable to the parent company
28.07%-42.75M
32.57%-9.63M
21.62%-12.33M
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
Preferred stock dividends
-143.22%-1.77M
115.32%2.63M
94.37%2.28M
-614.84%-8.71M
2.03M
148.57%4.08M
360.75%1.22M
137.25%1.17M
290.53%1.69M
Other preferred stock dividends
Net income attributable to common stockholders
35.47%-40.98M
20.93%-12.26M
13.58%-14.61M
73.17%-4.9M
28.19%-9.21M
0.51%-63.51M
-20.37%-15.51M
-4.82%-16.9M
1.00%-18.28M
21.64%-12.83M
Basic earnings per share
68.39%-0.61
22.10%-0.3194
48.98%-0.25
86.21%-0.08
55.56%-0.2
24.02%-1.93
21.15%-0.41
23.44%-0.49
21.62%-0.58
-160.81%-0.45
Diluted earnings per share
68.39%-0.61
22.10%-0.3194
48.98%-0.25
86.21%-0.08
55.56%-0.2
24.02%-1.93
21.15%-0.41
23.44%-0.49
21.62%-0.58
-160.81%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 32.86%27.04M110.29%7.6M111.00%7.42M1.67%6.26M-18.50%5.76M-26.41%20.35M-46.89%3.62M-46.74%3.52M-0.50%6.15M-12.33%7.07M
Operating revenue 32.86%27.04M110.29%7.6M111.00%7.42M1.67%6.26M-18.50%5.76M-26.41%20.35M-46.89%3.62M-46.74%3.52M-0.50%6.15M-12.33%7.07M
Cost of revenue -4.14%13.77M-2.35%3.4M21.94%3.55M-14.20%3.5M-14.67%3.33M-20.18%14.37M-14.55%3.48M-39.48%2.91M-19.17%4.08M-4.30%3.9M
Gross profit 121.71%13.27M3,083.33%4.2M535.57%3.88M32.88%2.76M-23.23%2.43M-38.02%5.98M-95.17%132K-66.11%610K82.25%2.07M-20.52%3.17M
Operating expense 14.22%71.01M10.62%15.87M-1.54%15.91M17.73%18.95M30.25%20.29M-6.46%62.17M22.19%14.35M-1.33%16.16M-12.97%16.09M-21.56%15.58M
Selling and administrative expenses 11.70%46.83M4.31%10.59M-0.29%10.46M11.64%12.14M31.06%13.65M-10.45%41.93M45.85%10.15M-9.33%10.49M-24.27%10.87M-25.26%10.41M
-Selling and marketing expense 10.78%26.35M20.62%5.58M5.81%6.73M10.40%7.13M8.99%6.91M-21.56%23.79M17.91%4.62M-15.96%6.36M-30.52%6.46M-33.51%6.34M
-General and administrative expense 12.91%20.48M-9.31%5.01M-9.69%3.73M13.44%5.01M65.44%6.74M9.99%18.14M81.88%5.53M3.23%4.13M-12.79%4.41M-7.37%4.07M
Research and development costs 19.41%24.18M25.86%5.28M-3.87%5.45M30.41%6.81M28.60%6.64M3.05%20.25M-12.25%4.2M17.95%5.67M26.23%5.22M-12.86%5.17M
Operating profit -2.77%-57.74M17.92%-11.67M22.62%-12.03M-15.49%-16.19M-43.90%-17.86M1.09%-56.19M-57.77%-14.22M-6.68%-15.55M19.22%-14.02M21.82%-12.41M
Net non-operating interest income expense -16.60%1.02M-28.38%3.42M-68.28%-313K200.62%2.58M7.83%-530K156.18%1.22M394.39%4.78M82.44%-186K-281.70%-2.57M-2,513.64%-575K
Non-operating interest income -40.26%1.12M-65.74%161K--------16.42%390K269.17%1.87M69.06%470K--------8,275.00%335K
Total other finance cost -85.12%96K24.30%-3.26M68.28%313K-200.62%-2.58M1.10%920K-20.07%645K-18,037.50%-4.31M-82.44%186K281.70%2.57M3,400.00%910K
Other net income (expense) 375.76%12.13M74.29%-1.23M5,732.91%9.22M-37.32%-4.4M-141.22%-4.78M818.18%158K
Gain on sale of security 375.76%12.13M74.29%-1.23M--------5,732.91%9.22M-37.32%-4.4M-141.22%-4.78M--------818.18%158K
Income before tax 24.87%-44.6M33.36%-9.48M21.54%-12.34M17.94%-13.61M28.51%-9.17M4.54%-59.36M-12.75%-14.22M-0.64%-15.73M8.00%-16.59M19.42%-12.83M
Income tax -2,993.75%-1.85M142.19%155K-13K0-1.99M1,500.00%64K2,033.33%64K000
Net income 28.07%-42.75M32.57%-9.63M21.62%-12.33M17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M
Net income continuous Operations 28.07%-42.75M32.57%-9.63M21.62%-12.33M17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M
Minority interest income
Net income attributable to the parent company 28.07%-42.75M32.57%-9.63M21.62%-12.33M17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M
Preferred stock dividends -143.22%-1.77M115.32%2.63M94.37%2.28M-614.84%-8.71M2.03M148.57%4.08M360.75%1.22M137.25%1.17M290.53%1.69M
Other preferred stock dividends
Net income attributable to common stockholders 35.47%-40.98M20.93%-12.26M13.58%-14.61M73.17%-4.9M28.19%-9.21M0.51%-63.51M-20.37%-15.51M-4.82%-16.9M1.00%-18.28M21.64%-12.83M
Basic earnings per share 68.39%-0.6122.10%-0.319448.98%-0.2586.21%-0.0855.56%-0.224.02%-1.9321.15%-0.4123.44%-0.4921.62%-0.58-160.81%-0.45
Diluted earnings per share 68.39%-0.6122.10%-0.319448.98%-0.2586.21%-0.0855.56%-0.224.02%-1.9321.15%-0.4123.44%-0.4921.62%-0.58-160.81%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meritage Homes
MTH
68.110
Amazon
AMZN
188.710
Strategy
MSTR
392.480
4
Salesforce
CRM
278.230
5
Meta Platforms
META
596.810
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Earnings Season Underway

Earnings season is here. What to know?